How Isansys saw the future

Changing healthcare is massively challenging, but that is what Isansys Lifecare has been doing slowly and steadily going from strength to strength since its launch 10 years ago. In a feature published in the Investor Magazine this week, journalist Rebecca Burn-Callander looks at how, when other companies were having to pause on trading during lockdown amid the Covid-19 pandemic, Isansys found itself having to adapt and scale up in a bid to meet demand for its remote patient monitoring technology and accelerate the deployment of its unique patient centric clinical infrastructure, the Patient Status Engine.

Keith Errey, CEO of Isansys, based in Oxfordshire, said: “We were selling a few monitoring packages a week, and then overnight we were hit with hundreds of orders.

“We are a manufacturer in a specialised industry, so it was a challenge to meet the sudden demand.”

Isansys moved quickly to ensure that essential components could be sourced from multiple suppliers, and then placed the orders to secure supply lines. Within two weeks, all Isansys staff apart from the manufacturing team were equipped with the technology to do their jobs from home, leaving space for production to continue with adequate social distancing and other health and safety measures in place.

“We put in VPN lines to ensure secure connectivity for the customer support teams,” said Keith. “We invested quickly and way beyond any pre-Covid budgets on these and other business upgrades, but with such large orders, these costs no longer looked so big.”

Many leaders would have balked at the challenge of scaling five-fold in a matter of days. But, with the help of Elephants Child, a growth advisory firm, Isansys was connected with the consultancy division at aerospace and automotive engineering firm Ricardo.

Working closely with Ricardo, Isansys production team devised ways to rapidly scale without compromising quality or health and safety during the height of the pandemic.

“Without the support, we would not have been able to come through the most difficult months of the COVID-19 crisis as successfully as we have done and, consequently, would not be positioned for future growth as strongly as we are now,” said Keith.

The pandemic has also helped prove that Isansys’ remote monitoring solutions and focus on automated patient data acquisition and analysis are key components for the future delivery of healthcare both in hospital and at home.

“We are not surprised by the sudden demand for the technology,” said Keith. “We have been working on this with care teams in different countries, for a long time, with the aim of driving this technology into a new standard of care. But what we see now is not a ‘disruption’; it is a rapid acceleration of a process already taking place. Isansys clearly has very interesting future.”

To read the full article, please click here.

Ends